N-(5-substituted thiazol-2-yl)-2-aryl-3-(tetrahydro-2H-pyran-4-yl) propanamides as glucokinase activators

MedChemComm

Volumn 2, Issue 6, 2011, Pages 531-535

  Liu, Zhiqing ^a   Zhu, Qingzhang ^a   Li, Fuying ^a,b   Zhang, Lina ^a   Leng, Ying ^a   Zhang, Ao ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME ACTIVATOR; GLUCOKINASE; N (5 THIAZOL 2 YL) 2 ARYL 3 (TETRAHYDRO 2H PYRAN 4 YL)PROPANAMIDE DERIVATIVE; PROPIONAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; GLUCOSE METABOLISM; GLYCOLYSIS; HYDROGEN BOND; HYDROLYSIS; HYDROPHILICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; STRUCTURE ACTIVITY RELATION;

EID: 79959207838     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c1md00002k     Document Type: Article

References (35)

1. M. L. Cárdenas (1995) Glucokinase: its regulation and role in liver metabolism, R.G. Landes Co, Austin.
2. A. M. Efanov, D. G. Barrett, M. B. Brenner, S. L. Briggs, A. Delaunois and J. D. Durbin, et al, Endocrinology, 2005, 146, 3696-3701.
3. F. M. Matschinsky, Diabetes, 1996, 45, 223-241.
4. F. M. Matschinsky and J. E. Ellerman, J. Biol. Chem., 1968, 243, 2730-2736.
5. A. L. Gloyn, S. Odili, C. Buettger, P. R. Njolstad, C. Chiyo, M. A. Magnuson, F. M. Matschinsky, In Glucokinase and Glycemic Disease: From Basics to Novel Therapeutics;Matschinksy, F. M.; Magnuson, M. A.; ed.; Karger: Basel, 2004; 92-109.
6. E. Van Schaftingen, Diabetologia, 1994, 37(Suppl. 2), S43-47.
7. D. Farrelly, K. S. Brown, A. Tieman, J. Ren, S. A. Lira, D. Hagan, R. Gregg, K. A. Mookhtiar and N. Hariharan, Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 14511-14516.
8. S. A. Ferris, Metab., Clin. Exp., 1964, 13, 1478-1481.
9. A. Basu, R. Basu, P. Shah, A. Vella, C. M. Johnson, K. S. Nair, M. D. Jensen, W. F. Schwenk and R. A. Rizza, Diabetes, 2000, 49, 272-283.
10. M. Hawkins, I. Gabriely, R. Wozniak, C. Vilcu, H. Shamoon and L. Rossetti, Diabetes, 2002, 51, 606-14.
11. L. Agius, Biochem. J., 2008, 414, 1-18.
12. J. Grimsby, R. Sarabu, W. L. Corbett, N.-E. Haynes and F. T. Bizzarro, et al, Science, 2003, 301, 370-373.
13. A. M. Efanov, D. G. Barrett, M. B. Brenner and S. L. Briggs, et al, Endocrinology, 2005, 146, 3696-3701.
14. R. Sarabu and J. Tilley, Annu. Rep. Med. Chem., 2005, 40, 167-181.
15. R. Sarabu and J. Grimsby, Curr. Opin. Drug Discovery Dev., 2005, 8, 631-637.
16. T. O. Johnson and P. S. Humphries, Annu. Rep. Med. Chem., 2006, 41, 141-154.
17. K. R. Guertin and J. Grimsby, Curr. Med. Chem., 2006, 13, 1839-1843.
18. M. C. T. Fyfe, J. White, A. Taylor, R. Chatfield and E. Wargent, et al, Diabetologia, 2007, 50, 1277-1287.
19. M. Coghlan and B. Leighton, Expert Opin. Invest. Drugs, 2008, 17, 145-167.
20. J. Grimsby, S. J. Berthel and R. Sarabu, Curr. Top. Med. Chem., 2008, 8, 1524-1532.
21. R. Sarabu, S. J. Berthel, R. F. K. Kester and J. W. T. Tilley, Expert Opin. Ther. Pat., 2008, 18, 759-768.
22. F. M. Matschinsky, Nat. Rev. Drug Discovery, 2009, 8, 399-416.
23. M. Pal, Curr. Med. Chem., 2009, 16, 3858-3874.
24. M. Pal, Drug Discovery Today, 2009, 14, 784-792.
25. (a) F. Li, Q. Zhu, Y. Zhang, Y. Feng, Y. Leng and A. Zhang, Bioorg. Med. Chem., 2010, 18, 3875-3884;
26. (b) Y. Zhang, Z. Han, F. Li, K.- L. Ding and A. Zhang, Chem. Commun., 2010, 46, 156-158.
27. L. S. Bertram, D. Black, P. H. Briner, R. Chatfield, A. Cooke and M. C. Fyfe, et al, J. Med. Chem., 2008, 51, 4340-4345.
28. P. H. Briner, M. C. T. Fyfe, J. P. Madeley, P. J. Murray, M. J. Procter, F. Spindler, World Patent Application No. WO 2006/016178.
29. K. Kamata, M. Mitsuya, T. Nishimura, J. Eiki and Y. Nagata, Structure, 2004, 12, 429-438.
30. J. Das, P. Chen, D. Norris, R. Padmanabha, J. Lin and R. V. Moquin, et al, J. Med. Chem., 2006, 49, 6819-6832.
31. M. D. Chappell, S. E. Conner, A. E. Tripp, G. Zhu, World Patent Application No. WO2006086488.
32. T. Sakamoto, H. Nagata, Y. Kondo, M. Shiraiwa and H. Yamanaka, Chem. Pharm. Bull., 1987, 35, 823-828.
33. V. V. Rostovtsev, L. G. Green, V. V. Fokin and K. B. Sharpless, Angew. Chem., Int. Ed., 2002, 41, 2596.
34. P. D. Pierson, A. Fettes, C. Freichel, S. Gatti-McArthur and C. Hertel, et al, J. Med. Chem., 2009, 52, 3855-3868.
35. T. Akiyama, H. Hirofuji and S. Ozaki, Tetrahedron Lett., 1991, 32, 1321-1324.